Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of LO2A eye drops in adults with conjunctivochalasis
MOH_2017-05-11_000412Phase 2Completed
- Sponsor
- Ocuwize LTD
- Start
- Jun 2016
- Modality
- Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in conjunctivochalasis (CCH) and dry eye syndrome (DED) comparing LO2A with Placebo (2 arms). Started Jun 2016; status: completed.
02
Drugs
LO2A
03
Conditions
conjunctivochalasis (CCH)dry eye syndrome (DED)
Beyond the preview
Go deeper on MOH_2017-05-11_000412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-05-11_000412.